Yale Cancer Center member Sidi Chen, assistant professor of Genetics at Yale School of Medicine, and a member of the Yale West Campus Systems Biology Institute, was awarded a $500,000 research grant from Alliance for Cancer Gene Therapy to advance multiplexed activation of endogenous genes as an Immunotherapy or MAEGI technology.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
